ginsenoside Re
(PWAOOJDMFUQOKB-WCZZMFLVSA-N)
Structure
- SMILES
- OC[C@H]1O[C@@H](O[C@H]2C[C@]3(C)[C@@H]([C@@]4([C@@H]2C(C)(C)[C@@H](O)CC4)C)C[C@H]([C@H]2[C@@]3(C)CC[C@@H]2[C@@](O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)(CCC=C(C)C)C)O)[C@@H]([C@H]([C@@H]1O)O)O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O
- Type(s)
- Investigational
- Molecular Formula:
- C48H82O18
- Molecular Weight:
- 947.154
- Log P:
- -0.0284
- Hydrogen Bond Acceptor:
- 18
- Hydrogen Bond Donor:
- 12
- TPSA:
- 298.14
- CAS Number(s):
- 51542-56-4; 52286-59-6
Synonym(s)
1.
ginsenoside Re
2.
ginsenoside-Re
External Link(s)
| MeSH | C049864 |
| PubChem Compound | 441921 |
| BindingDB | 50378779 |
| ChEBI | 77148 |
| CHEMBL | CHEMBL510095 |
| DrugBank | DB14815 |
| KEGG | cpd:C08944 |
| ZINC | 242620164 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Brain Ischemia | 18464084 | CTD | |
| 2 | Candidiasis | 22940185 | CTD | |
| 3 | Colitis | 22849695 | CTD | |
| 4 | Diabetes Mellitus, Experimental | 16797897 | CTD | |
| 5 | Edema | 22494059 | CTD | |
| 6 | Hyperalgesia | 24709919 | CTD | |
| 7 | Hyperglycemia | 15949698 17885204 | CTD | |
| 8 | Inflammation | 16797897 22494059 22849695 | CTD | |
| 9 | Insulin Resistance | 17885204 22571876 23545455 | CTD | |
| 10 | Myocardial Infarction | 24781185 | CTD | |
| 11 | Neurogenic Inflammation | 23102375 | CTD | |
| 12 | Parkinsonian Disorders | 15621629 | CTD | |
| 13 | Pruritus | 22855946 | CTD | |
| 14 | Reperfusion Injury | 18464084 | CTD | |
| 15 | Substance Withdrawal Syndrome | 24709919 | CTD | |
| 16 | Toxoplasmosis | 23896123 | CTD | |
| 17 | Vomiting | 15791456 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.